Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Tuberculosis

Free Subscription Articles published in J Infect Retrieve available abstracts of 35 articles: HTML format

Single Articles

November 2022
1. CALDERWOOD CJ, Reeve BW, Mann T, Palmer Z, et al
   Clinical utility of C-reactive protein-based triage for presumptive pulmonary tuberculosis in South African adults.
   J Infect. 2022 Nov 11. pii: S0163-4453(22)00639.
   PubMed     Abstract available
   
   
   September 2022
2. ZHOU Y, Anthony R, Wang S, Ou X, et al
   Corrigendum to 'The epidemic of multidrug resistant tuberculosis in China in historical and phylogenetic perspectives' [Journal of Infection, Volume 80, Issue 4 (2020) Pages 444-453].
   J Infect. 2022 Sep 29. pii: S0163-4453(22)00543.
   PubMed    
   
   
   August 2022
3. CHEN YC, Hsiao CC, Wu CC, Chao TY, et al
   Next generation sequencing reveals miR-431-3p/miR-1303 as immune-regulating microRNAs for active tuberculosis.
   J Infect. 2022 Aug 31. pii: S0163-4453(22)00517.
   PubMed     Abstract available
   
   
   
4. XU Y, Tan Y, Zhang X, Cheng M, et al
   Comprehensive identification of immuno-related transcriptional signature for active pulmonary tuberculosis by integrated analysis of array and single cell RNA-seq.
   J Infect. 2022 Aug 22. pii: S0163-4453(22)00501.
   PubMed     Abstract available
   
   
   
5. LEE DG, Kim HJ, Park MJ, Hong JH, et al
   Proteomic analysis of sequential isolates of multidrug-resistant Mycobacterium tuberculosis during treatment failure: Altered protein expression in failed MDR-TB treatment.
   J Infect. 2022 Aug 17. pii: S0163-4453(22)00473.
   PubMed    
   
   
   July 2022
6. YAN Y, Davgadorj C, Lyu C, Zhang S, et al
   Immunogenicity of a third dose of inactivated COVID-19 vaccine in people living with HIV-1, HBV, and tuberculosis during the Omicron variant epidemic: a cross-sectional study.
   J Infect. 2022 Jul 5. pii: S0163-4453(22)00407.
   PubMed    
   
   
   
7. DHANA A, Hamada Y, Kengne AP, Kerkhoff AD, et al
   Diagnostic accuracy of WHO screening criteria to guide lateral-flow lipoarabinomannan testing among HIV-positive inpatients: A systematic review and individual participant data meta-analysis.
   J Infect. 2022;85:40-48.
   PubMed     Abstract available
   
   
   June 2022
8. TUNESI S, Du DL, Gualano G, Millet JP, et al
   Co-administration of treatment for rifampicin-resistant TB and chronic HCV infection: A TBnet and ESGMYC study.
   J Infect. 2022;84:834-872.
   PubMed    
   
   
   May 2022
9. BACHIR M, Guglielmetti L, Tunesi S, Billard-Pomares T, et al
   Molecular detection of isoniazid monoresistance improves tuberculosis treatment: a retrospective cohort in France.
   J Infect. 2022 May 20. pii: S0163-4453(22)00306.
   PubMed     Abstract available
   
   
   
10. WYLLIE D, Do T, Myers R, Nikolayevskyy V, et al
    M. tuberculosis microvariation is common and is associated with transmission: analysis of three years prospective universal sequencing in England.
    J Infect. 2022 May 17. pii: S0163-4453(22)00294.
    PubMed     Abstract available
    
    
    
11. CHEN Y, Liu Q, Takiff HE, Gao Q, et al
    Comprehensive genomic analysis of Mycobacterium tuberculosis reveals limited impact of high-fitness genotypes on MDR-TB transmission.
    J Infect. 2022 May 16. pii: S0163-4453(22)00293.
    PubMed     Abstract available
    
    
    April 2022
12. LIU Q, Chen X, Liu X, Yang D, et al
    Cervical lymph node dissection on the treatment of cervical tuberculosis.
    J Infect. 2022 Apr 25. pii: S0163-4453(22)00242.
    PubMed    
    
    
    January 2022
13. LUO Y, Xue Y, Song H, Tang G, et al
    Machine learning based on routine laboratory indicators promoting the discrimination between active tuberculosis and latent tuberculosis infection.
    J Infect. 2022 Jan 4. pii: S0163-4453(21)00666.
    PubMed     Abstract available
    
    
    
14. LUCEY O, Potter J, Ricketts W, Castle L, et al
    Utility of EBUS-TBNA in diagnosing mediastinal tuberculous lymphadenitis in East London.
    J Infect. 2022;84:17-23.
    PubMed     Abstract available
    
    
    October 2021
15. MONICA R, Lin NW, Laura D, Fidelma F, et al
    Latent tuberculosis infection amongst patients with rheumatic diseases in an Irish Tertiary Referral Centre - A five-year review.
    J Infect. 2021 Oct 27. pii: S0163-4453(21)00510.
    PubMed    
    
    
    August 2021
16. DAI Y, Xie L, Wang X, Zhang H, et al
    Depression increases the risk of tuberculosis: preliminary observations.
    J Infect. 2021 Aug 6. pii: S0163-4453(21)00369.
    PubMed    
    
    
    July 2021
17. CHENDI BH, Tveiten H, Snyders CI, Tonby K, et al
    CCL1 and IL-2Ra differentiate Tuberculosis disease from latent infection Irrespective of HIV infection in low TB burden countries.
    J Infect. 2021 Jul 29. pii: S0163-4453(21)00379.
    PubMed     Abstract available
    
    
    
18. RAJAMANICKAM A, Kumar NP, Padmapriyadarsini C, Nancy A, et al
    Latent tuberculosis co-infection is associated with heightened levels of humoral, cytokine and acute phase responses in seropositive SARS-CoV-2 infection.
    J Infect. 2021 Jul 27. pii: S0163-4453(21)00372.
    PubMed     Abstract available
    
    
    
19. TAN Y, Deng Y, Yan X, Liu F, et al
    Nontuberculous mycobacterial pulmonary disease and associated risk factors in China: A prospective surveillance study.
    J Infect. 2021;83:46-53.
    PubMed     Abstract available
    
    
    
20. SONG Y, Dong Y, Liao Y, Liang Z, et al
    Apoptotic caspases suppress Mycobacterium bovis-induced IFN-beta production in murine macrophage.
    J Infect. 2021;83:61-68.
    PubMed     Abstract available
    
    
    May 2021
21. DILLARD LK, Martinez RX, Perez LL, Fullerton AM, et al
    Prevalence of aminoglycoside-induced hearing loss in drug-resistant tuberculosis patients: A systematic review: Ototoxic hearing loss in drug-resistant tuberculosis.
    J Infect. 2021 May 17. pii: S0163-4453(21)00252.
    PubMed     Abstract available
    
    
    
22. SAM IK, Chen YY, Ma J, Li SY, et al
    TB-QUICK: CRISPR-Cas12b-assisted rapid and sensitive detection of Mycobacterium tuberculosis.
    J Infect. 2021 May 2. pii: S0163-4453(21)00219.
    PubMed     Abstract available
    
    
    February 2021
23. LIU Q, Fang X, Chen X, Dai X, et al
    Letter to the editor: Application of the Xpert MTB/RIF technology in the diagnosis and treatment of osteoarticular tuberculosis.
    J Infect. 2021 Feb 20. pii: S0163-4453(21)00092.
    PubMed    
    
    
    
24. WANG G, Jiang G, Jing W, Zong Z, et al
    Prevalence and molecular characterizations of seven additional drug resistance among multidrug-resistant tuberculosis in China: a subsequent study of a national survey.
    J Infect. 2021 Feb 5. pii: S0163-4453(21)00055.
    PubMed     Abstract available
    
    
    
25. PATTERSON B, Abbara A, Collin S, Henderson M, et al
    Predicting drug-induced liver injury from anti-tuberculous medications by early monitoring of liver tests.
    J Infect. 2021;82:240-244.
    PubMed     Abstract available
    
    
    January 2021
26. LOGAN C, Mullender C, Mirfenderesky M, Feasey N, et al
    Presentations and outcomes of central nervous system TB in a UK cohort: The high burden of neurological morbidity.
    J Infect. 2021;82:90-97.
    PubMed     Abstract available
    
    
    
27. AHN CS, Shin JW, Kim JG, Lee WY, et al
    Spectrum of pleuropulmonary paragonimiasis: An analysis of 685 cases diagnosed over 22 years.
    J Infect. 2021;82:150-158.
    PubMed     Abstract available
    
    
    
28. HEAD IM, Lazarus R
    Use of Xpert MTB/RIF in a low prevalence setting in the Southwest of England.
    J Infect. 2021;82:159-198.
    PubMed    
    
    
    December 2020
29. IZZARD A, Wilders S, Smith C, Wickers M, et al
    Improved treatment completion for Tuberculosis patients: the case for a dedicated social care team.
    J Infect. 2020 Dec 23. pii: S0163-4453(20)30780.
    PubMed     Abstract available
    
    
    
30. MARINE E, Loic H, Christelle GC, Pierre-Louis N, et al
    Improving tuberculosis management in prisons: impact of a rapid molecular point-of-care test.
    J Infect. 2020 Dec 4. pii: S0163-4453(20)30764.
    PubMed     Abstract available
    
    
    
31. ADANKWAH E, Nausch N, Minadzi D, Abass MK, et al
    Interleukin-6 and Mycobacterium tuberculosis dormancy antigens improve diagnosis of tuberculosis.
    J Infect. 2020 Dec 2. pii: S0163-4453(20)30729.
    PubMed     Abstract available
    
    
    
32. LIU XH, Xia L, Song B, Wang H, et al
    Stool-based Xpert MTB/RIF Ultra Assay as a tool for detecting pulmonary tuberculosis in children with abnormal chest imaging: a prospective cohort study.
    J Infect. 2020 Dec 1. pii: S0163-4453(20)30727.
    PubMed     Abstract available
    
    
    November 2020
33. VAN ZYL CW, Loots DT, Solomons R, van Reenen M, et al
    Metabolic characterization of tuberculous meningitis in a South African paediatric population using (1)H NMR metabolomics.
    J Infect. 2020;81:743-752.
    PubMed     Abstract available
    
    
    September 2020
34. SUDBURY EL, Clifford V, Messina NL, Song R, et al
    Mycobacterium tuberculosis-specific cytokine biomarkers to differentiate active TB and LTBI: A systematic review.
    J Infect. 2020 Sep 29. pii: S0163-4453(20)30631.
    PubMed     Abstract available
    
    
    August 2020
35. CAPOCCI SJ, Sewell J, Smith C, Cropley I, et al
    Cost effectiveness of testing HIV infected individuals for TB in a low TB/HIV setting.
    J Infect. 2020;81:289-296.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Tuberculosis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: